CC
IDYA icon

Callan Capital’s IDEAYA Biosciences IDYA Stock Holding History

Callan Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,726
Closed -$213K – 357
2024
Q3 		$213K Hold
6,726
– – 0.01% 323
2024
Q2 		$236K Hold
6,726
– – 0.02% 277
2024
Q1 		$295K Hold
6,726
– – 0.03% 208
2023
Q4 		$239K Buy
+6,726
New +$201K 0.02% 195

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Callan Capital's IDYA Position: Q4 2024 in Review

Callan Capital sold out of IDEAYA Biosciences (IDYA) in Q4 2024, closing a stake of 6,726 shares — an estimated $213K sold.

Callan Capital first reported a position in IDYA in Q4 2023 and held it in 4 quarters. The position peaked at $295K in Q1 2024. 206 funds tracked by Wall St. Rank hold IDYA as of Q4 2024.

  • Callan Capital reported no remaining IDEAYA Biosciences position as of Q4 2024 after selling out during the quarter.
  • Callan Capital sold 6,726 IDEAYA Biosciences shares in Q4 2024, an estimated $213K.
  • Callan Capital first reported a position in IDEAYA Biosciences in Q4 2023 and held it in 4 quarters.
  • Callan Capital's IDEAYA Biosciences position peaked at $295K in Q1 2024.
  • 206 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2024.

Based on Callan Capital's 13F filing for Q4 2024, filed 3 Feb 2025.